First Trust Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
First Trust Advisors's HCAT Position: Q2 2022 in Review
First Trust Advisors sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 10,408 shares — an estimated $272K sold.
First Trust Advisors first reported a position in HCAT in Q4 2020 and held it in 6 quarters. The position peaked at $5.75M in Q3 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.
- First Trust Advisors reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
- First Trust Advisors sold 10,408 Health Catalyst shares in Q2 2022, an estimated $272K.
- First Trust Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 6 quarters.
- First Trust Advisors's Health Catalyst position peaked at $5.75M in Q3 2021.
- 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.
Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.